Ab Index-Nr. 613-182-00-7

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
613-182-00-71-(1-naphthylmethyl)quino-
linium chloride
406-220-765322-65-8Carc. 2
Muta. 2
Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H351
H341
H302
H315
H318
H412
GHS08
GHS05
GHS07
Dgr
H351
H341
H302
H315
H318
H412
   
613-183-00-2reaction mass of: 5-(N-methyl-
perfluorooctylsulfonami-
do)methyl-3-octadecyl-1,3-
oxa-zolidin-2-one;
5-(N-methylperfluoroheptyl-
sulfonamido)methyl-3-octa-
decyl-1,3-oxazolidin-2-one
413-640-4STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1
H373 (*)(*)
H400
H410
GHS08
GHS09
Wng
H373 (*)(*)
H410
   
613-184-00-8nitrilotriethyleneammonio-
propane-2-ol 2-ethylhexanoate
413-670-8Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
   
613-185-00-32,3,5,6-tetrahydro-2-methyl-
2H-cyclopenta[d]-1,2-thiazol-
3-one
407-630-982633-79-2Acute Tox. 3 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H318
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H301
H318
H317
H410
   
613-186-00-9(2R,3R)-3-((R)-1-(tert-butyldi-
methylsiloxy)ethyl)-4-
oxoazetidin-2-yl acetate
408-050-976855-69-1Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H317
H411
GHS07
GHS09
Wng
H319
H317
H411
   
613-187-00-45-(2-amino-5-cyano-6-[2-(2-
hydroxyethoxy)ethylamino]-4-
methylpyridin-3-ylazo)-3-methyl-
2,4-dicarbonitrilethiophene
410-530-8Skin Sens. 1H317GHS07
Wng
H317   
613-188-00-X1-(3-(4-fluorophenoxy)propyl)-
3-methoxy-4-piperidinone
411-500-7116256-11-2Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
   
613-189-00-51,4,7,10-tetrakis(p-toluen-
sulfonyl)-1,4,7,10-tetra-
azacyclododecane
414-030-052667-88-6Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
613-190-00-0disodium 1-amino-4-(2-
(5-chloro-6-fluoropyrimidin-
4-ylamino-methyl)-4-methyl-
6-sulfo-phenylamino)-9,10-
dioxo-9,10-dihydro-anthracene-
2-sulfonate
414-040-5149530-93-8Acute Tox. 4 (*)
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
   
613-191-00-63-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxa-
zolidine
421-150-7143860-04-2Repr. 1B
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360F
(*)(*)(*)
H314
H400
H410
GHS08
GHS05
GHS09
Dgr
H360F
(*)(*)(*)
H314
H410
   
613-192-00-13-benzyl-exo-6-nitro-2,4-dioxo-3-
aza-cis-bicyclo[3.1.0]hexane
426-750-2151860-15-0Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
613-193-00-7pentakis[3-(dimethylammo-
nio)propylsulfamoyl]-[(6-
hydroxy-4,4,8,8-tetramethyl-
4,8-diazoniaundecane-1,11-
diyldisulfamoyl)di
[phthalocyaninecopper(II)]] heptalactate
414-930-3Aquatic Chronic 2H411GHS09H411   
613-194-00-26,13-dichloro-3,10-bis{2-[4-
fluoro-6-(2-sul-fophenylamino)-
1,3,5-triazin-2-ylamino]
propylamino}ben-
zo[5,6][1,4]oxazi-
no[2,3-.b.]phenoxazine-4,11-
disulphonic acid,
lithium-, sodium salt
418-000-8163062-28-0Eye Dam. 1H318GHS05
Dgr
H318   
613-195-00-82,2-(1,4-phenylene)bis((4H-
3,1-benzoxazine-4-one)
418-280-118600-59-4Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
613-196-00-35-[[4-chloro-6-[[2-[[4-fluoro-
6-[[5-hydroxy-6-[(4-methoxy-
2-sulfophenyl)azo]-7-sulfo-
2-naphthalenyl]amino]-1,3,5-
triazin-2-yl]amino]-1-methyl-
ethyl]amino]-1,3,5-triazin-
2-yl]amino]-3-[[4-(ethenyl-
sulfonyl)phenyl]azo]-4-
hydroxy-naphtalene-2,7-
disulfonic acid, sodium salt
418-380-5168113-78-8Eye Dam. 1H318GHS05
Dgr
H318   
613-197-00-9reaction mass of: 2,4,6-tri(butyl-
carbamoyl)-1,3,5-triazine;
2,4,6-tri(methylcarba-
moyl)-1,3,5-triazine;
[(2-butyl-4,6-dimethyl)tri-
carbamoyl]-1,3,5-triazine;
[(2,4-dibutyl-6-methyl)tricar-
bamoyl]-1,3,5-triazine
420-390-1187547-46-2Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
613-198-00-42-amino-4-dimethylamino-6-
trifluoroethoxy-1,3,5-triazine
415-500-8145963-84-4Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H302
H373 **
H412
GHS08
GHS07
Wng
H302
H373 **
H412
   
613-199-00-Xreaction mass of:
1,3,5-tris(3-aminomethyl-
phenyl)-1,3,5-(1H,3H,5H)-
triazine-2,4,6-trione;
reaction mass of oligomers of
3,5-bis(3-aminomethylphe-
nyl)-1-poly[3,5-bis(3-amino-
methylphenyl)-2,4,6-trioxo-
1,3,5-(1H,3H,5H)-triazin-1-
yl]-1,3,5-(1H,3H,5H)-
triazine-2,4,6-trione
421-550-1Carc. 1B
Repr. 1B
Skin Sens. 1
Aquatic Chronic 3
H350
H360D
(*)(*)(*)
H317
H412
GHS08
Dgr
H350
H360D
(*)(*)(*)
H317
H412
   
613-200-00-3Reaction product of: copper, (29H,31H-phthalocyanina-
to(2-)-N29,N30,N31,N32)-,
chlorosulfuric acid and 3-(2-sul-
fooxyethylsulfonyl)aniline, sodium salts
420-980-7Eye Dam. 1H318GHS05
Dgr
H318   
613-201-00-9(R)-5-bromo-3-(1-methyl-2-
pyrrolidinylmethyl)-1H-indole
422-390-5143322-57-0Repr. 2
STOT RE 1
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f
(*)(*)(*)
H372 (*)(*)
H332
H302
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H361f
(*)(*)(*)
H372 (*)(*)
H332
H302
H317
H410
EUH070  
613-202-00-4pymetrozine (ISO);
(E)-4,5-dihydro-6-methyl-4-
(3-pyridylmethyleneamino)-
1,2,4-triazin-3(2H)-one
123312-89-0Carc. 2
Aquatic Chronic 3
H351
H412
GHS08
Wng
H351
H412
   
613-203-00-Xpyraflufen-ethyl (ISO);
2-chloro-5-(4-chloro-5-difluoro-
methoxy-1-methylpyrazol-3-
yl)-4-fluorophenoxyacetic acid ethyl ester; [1]
pyraflufen (ISO);
2-chloro-5-(4-chloro-5-difluoro-
methoxy-1-methylpyrazol-3-
yl)-4-fluorophenoxyacetic acid [2]
- [1]
- [2]
129630-19-9 [1]
129630-17-7 [2]
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 1000 
613-204-00-5oxadiargyl (ISO);
3-[2,4-dichloro-5-(2-propyny-
loxy)phenyl]-5-(1,1-dimethyl-
ethyl)-1,3,4-oxadiazol-2(3H)-one
254-637-639807-15-3Repr. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H361d ***
H373 **
H400
H410
GHS08
GHS09
Dgr
H361d ***
H373 **
H410
 M = 1000 
613-205-00-0propiconazole(ISO);
(±) 1-[2-(2,4-dichlorophenyl)-
4-propyl-1,3-dioxolan-2-
ylmethyl]-1H-1,2,4-triazole
262-104-460207-90-1Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
   
613-206-00-6fenamidone (ISO);
(S)-5-methyl-2-methylthio-
5-phenyl-3-phenylamino-
3,5-dihydroimidazol-4-one
161326-34-7Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
613-208-00-7imazamox (ISO);
(RS)-2-(4-isopropyl-4-methyl-
5-oxo-2-imidazolin-2-yl)-5-
methoxymethylnicotinic acid
114311-32-9Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
613-209-00-2cis-1-(3-chloropropyl)-2,6-
dimethyl-piperidin hydrochloride
417-430-363645-17-0Acute Tox. 3 (*)
STOT RE 2 (*)
Skin Sens. 1
Aquatic Chronic 2
H301
H373 (*)(*)
H317
H411
GHS06
GHS08
GHS09
Dgr
H301
H373 (*)(*)
H317
H411
   
613-210-00-82-(3-chloropropyl)-2,5,5-tri-
methyl-1,3-dioxane
417-650-188128-57-8STOT RE 2 (*)
Aquatic Chronic 3
H373 (*)(*)
H412
GHS08
Wng
H373 (*)(*)H412   
613-211-00-3N-methyl-4-(p-formylsty-
ryl)pyridiniummethylsulfate
418-240-374401-04-0Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
613-212-00-94-[4-(2-ethylhexyloxy)phe-
nyl](1,4-thiazinane-1,1-dioxide)
418-320-8133467-41-1Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
613-213-00-4cis-1-benzoyl-4-[(4-methyl-
sulfonyl)oxy]-L-proline
416-040-0120807-02-5Aquatic Chronic 3H412H412   
613-214-00-XN,N-di-n-butyl-2-(1,2-dihydro-
3-hydroxy-6-isopropyl-2-
quinolylidene)-1,3-dioxoindan-
5-carboxamide
416-260-7147613-95-4Aquatic Chronic 4H413H413   
613-215-00-52-chloromethyl-3,4-dimethoxy-
pyridinium chloride
416-440-572830-09-2Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H312
H302
H373 (*)(*)
H315
H318
H317
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H312
H302
H373 (*)(*)
H315
H318
H317
H411
   
613-216-00-06-tert-butyl-7-(6-diethylami-
no-2-methyl-3-pyridylimi-
no)-3-(3-methylphenyl)pyrazo-
lo[3,2-c][1,2,4]triazole
416-490-8162208-01-7Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
613-217-00-64-[3-(3,5-di-tert-butyl-4-hy-
droxyphenyl)propionyloxy]-
1-[2-[3-(3,5-di-tert-butyl-4-hyd-
rophenyl)propionyloxy]ethyl]-
2,2,6,6-tetramethylpiperidine
416-770-173754-27-5Aquatic Chronic 4H413H413   
613-218-00-16-hydroxyindole417-020-42380-86-1Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
   
613-219-00-77a-ethyl-3,5-bis(1-methyl-
ethyl)-2,3,4,5-tetrahydrooxa-
zolo[3,4-c]-2,3,4,5-tetrahydro-
oxazole
417-140-779185-77-6Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
   
613-220-00-2trans-(4S,6S)-5,6-dihydro-6-
methyl-4H-thieno[2,3-b]thio-
pyran-4-ol, 7,7-dioxide
417-290-3147086-81-5Acute Tox. 4 (*)H302GHS07
Wng
H302   
613-221-00-82-chloro-5-methyl-pyridine418-050-018368-64-4Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Chronic 3
H312
H302
H315
H412
GHS07
Wng
H312
H302
H315
H412
   
613-222-00-34-(1-oxo-2-propenyl)-morpholine418-140-15117-12-4Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
H302
H373 (*)(*)
H318
H317
GHS08
GHS05
GHS07
Dgr
H302
H373 (*)(*)
H318
H317
   
613-223-00-9N-isopropyl-3-(4-fluorophe-
nyl)-1H-indole
418-790-493957-49-4Aquatic Chronic 4H413H413   
613-224-00-42,5-dimercaptomethyl-1,4-
dithiane
419-770-8136122-15-1Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H317
H410
   
613-225-00-Xreaction mass of:
[2-(anthraquinon-1-yla-
mino)-6-[(5-benzoylamino)-
anthraquinone-1-ylamino]-4-
phenyl]-1,3,5-triazine;
2,6-bis-[(5-benzoylamino)-
anthraquinon-1-ylamino]-4-
phenyl-1,3,5-triazine
421-290-9STOT RE 2 (*)
Aquatic Chronic 4
H373 (*)(*)
H413
GHS08
Wng
H373 (*)(*)
H413
   
613-226-00-51-(2-(ethyl(4-(4-(4-(4-(ethyl(2-
pyridinoethyl)amino)-2-
methylphenylazo)benzoyl-
amino)-phenylazo)-3-methyl-
phenyl)amino)ethyl)-
pyridinium dichloride
420-950-3163831-67-2Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
   
613-227-00-0(±)-[(R(*),R(*)) and (R(*),S(*))]-
6-fluoro-3,4-dihydro-2-
oxiranyl-2H-1-benzopyran
419-600-299199-90-3Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
613-228-00-6(±)-(R(*),S(*))-6-fluoro-
3,4-dihydro-2-oxira-
nyl-2H-1-benzopyran
419-630-6793669-26-8Aquatic Chronic 2H411GHS09H411   
613-229-00-11-acetyl-4-(3-dodecyl-2,5-
dioxo-1-pyrrolidinyl)-2,2,6,6-
tetramethylpiperidine
411-930-5106917-31-1Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410
   
613-230-00-7florasulam (ISO);
2',6',8-trifluoro-5-methoxy-5-
triazolo[1,5-c];
pyrimidine-2-sulfonanilide
145701-23-1Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
613-231-00-22,6-diamino-3-((pyridine-3-yl)
azo)pyridine
421-430-928365-08-4Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H302
H373 **
H411
GHS08
GHS07
GHS09
Wng
H302
H373 **
H411
   
613-232-00-83-(benzo[b]thien-2-yl)-5,6-
dihydro-1,4,2-oxathiazine-
4-oxide
431-030-6163269-30-5Acute Tox. 3 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H373 **
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H331
H373 **
H318
H410
   
613-233-00-34,4'-(oxy-(bismethylene))-bis-
1,3-dioxolane
423-230-756552-15-9Eye Dam. 1H318GHS05
Dgr
H318   
613-234-00-9imidazo[1,2-b]pyridazin hydrochloride431-510-518087-70-2Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
   
613-235-00-42,3-dihydro-2,2-dimethyl-1H-
perimidine
424-060-66364-17-6Acute Tox. 4*
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 **
H317
H410
   
613-236-00-X2-chloro-3-trifluoromethyl-
pyridine
424-520-665753-47-1Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Chronic 3
H311
H301
H372 **
H314
H412
GHS06
GHS05
GHS08
Dgr
H311
H301
H372 **
H314
H412
   
613-237-00-56-tert-butyl-3-(3-dodecyl-
sulfonyl)propyl-7H-1,2,4-
triazolo[3.4b][1,3,4]thiadiazine
424-950-4133949-92-5Aquatic Chronic 4H413H413   
613-238-00-0sodium 2-[[4-[(4,6-dichloro-
1,3,5-triazin-2-yl)amino]phe-
nyl]sulfonyl]ethyl sulfate
430-890-181992-66-7Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
613-239-00-62-[3-(methylamino)propyl]-1H-
benzimidazole
425-760-464137-52-6Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
613-241-00-73-(2H-tetrazol-5-yl)pyridine426-810-83250-74-6Eye Dam. 1H318GHS05
Dgr
H318   
613-242-00-2reaction products of
3,10-bis((2-aminopropyl)amino)-
6,13-dichloro-4,11-
triphenodioxazinedisulfonic acid with 2-amino-1,4-benzene-
disulfonic acid,
2-((4-aminophenyl)sulfo-
nyl)ethylhydrogen sulfate and
2,4,6-trifluoro-1,3,5-triazine, sodium salts
426-860-0191877-09-5Eye Dam. 1H318GHS05
Dgr
H318   
613-243-00-84,4´-(1,6-hexamethylenebis
(formylimino))bis(2,2,6,6-
tetramethyl-1-oxylpiperidine)
427-350-0182235-14-9Aquatic Chronic 2H411GHS09H411   
613-244-00-35,7-dichloro-4-hydroxyquinoline427-420-021873-52-9Aquatic Chronic 2H411GHS09H411   
613-245-00-92-fluoro-6-trifluoromethyl-
pyridine
428-100-394239-04-0Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H226
H332
H302
H412
GHS02
GHS07
Wng
H226
H332
H302
H412
   
613-246-00-42-hydroxymethyl-3-methyl-
4-(2,2,2-trifluoroethoxy)pyridine
428-200-7103577-66-8Aquatic Chronic 3H412H412   
613-247-00-X3-(2-methoxy-4-
methoxycarboxybenzyl)-5-
nitroindole
428-910-7107786-36-7Aquatic Chronic 4H413H413   
613-248-00-53,4-dimethyl-1H-pyrazole429-130-12820-37-3Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
   
613-249-00-01-(2-hydroxyethyl)-1H-pyrazol-
4,5-diyldiammoniumsulfate
429-300-3155601-30-2Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411
   
613-250-00-6reaction mass of:
carbonato-bis-N-
ethyl-2-isopropyl-1,3-
oxazolidine;
methyl carbonato-N-ethyl-2-
isopropyl-1,3-oxazolidine;
2-isopropyl-N-hydroxyethyl
1,3-oxazolidine
429-990-6Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
   
613-251-00-1(R)-3-[(1-methylpyrrolidin-2-
yl)methyl]-5-[2-(phenylsulfonyl)
ethenyl]-1H-indole
430-560-5180637-89-2Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H302
H373 **
H318
H317
GHS05
GHS08
GHS07
Dgr
H302
H373 **
H318
H317
   
613-253-00-22,2-dialkyl-4-hydroxymethyl-
1,3-dioxolane;
reaction products with ethyleneoxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3,5)
430-580-4Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
EUH019  
613-254-00-8forchlorfenuron (ISO);
1-(2-chloro-4-pyridyl)-3-
phenylurea
68157-60-8Carc. 2
Aquatic Chronic 2
H351
H411
GHS08
GHS09
Wng
H351
H411
   
613-255-00-3reaction mass of isomers of: sodium
[(2-hydroxyethylsulfamoyl)
{[2-(2-piperazin-1-
ylethylamino)ethylsulfamoyl]
[2-(4-aminoethylpiperazine-1-yl)
ethylsulfamoyl](sulfamoyl)}
(sulfonatophthalocyaninato)]
copper(II)
424-270-8Eye Dam. 1H318GHS05
Dgr
H318   
613-256-00-93´5´-anhydro thymidine425-810-538313-48-3Aquatic Chronic 3H412H412   
613-257-00-42-phthalimidoethyl N-[4-(2-
cyano-4-nitrophenylazo)phe-
nyl]-N-methyl-β-alaninate
426-400-9170222-39-6Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
613-258-00-Xreaction mass of: 4-chloro-7-
methylbenzotriazole sodium salt;
4-chloro-5-methylbenzotriazole
sodium salt;
5-chloro-4-methylbenzotriazole
sodium salt
427-730-6202420-04-0Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412
   
613-259-00-5reaction mass of: [2,4-dioxo-
(2-propyn-1-yl)imidazolidin-3-
yl]methyl(1R)-cis-chrysan-
themate;
[2,4-dioxo-(2-propyn-1-
yl)imidazolidin-3-yl]me-
thyl(1R)-trans-chrysanthemate
428-790-672963-72-5Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
613-260-00-0(±)-4-(3-chlorophenyl)-6-
[(4-chlorophenyl)hydroxy
(1-methyl-1H-imidazol-5-
yl)methyl]-1-methyl-2(1H)-
quinolin
430-730-9Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
   
613-261-00-6pyrazole-1-carboxamidine monohydrochloride429-520-14023-02-3Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H373 **
H318
H317
H412
GHS05
GHS08
GHS07
Dgr
H302
H373 **
H318
H317
H412
   
613-262-00-1disodium (E)-1,2-bis-(4-(4-
methylamino-6-(4-
methylcarbamoylphenylamino)-
1,3,5-triazin-2-ylamino)phenyl-2-
sulfonato)ethene
427-310-2180850-95-7Eye Dam. 1H318GHS05
Dgr
H318   
613-263-00-7monosodium 3-cyano-5-
fluoro-6-hydroxypyridine-2-olate
429-570-2Skin Sens. 1H317GHS07
Wng
H317   
613-266-00-32-chloro-5-chloromethyl-
thiazole
429-830-5105827-91-6Acute Tox. 3 *
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H311
H314
H302
H317
H411
GHS06
GHS05
GHS09
Dgr
H311
H314
H302
H317
H411
   
613-267-00-9thiamethoxam (ISO);
3-(2-chloro-thiazol-5-ylme-
thyl)-5-methyl[1,3,5]oxadia-
zinan-4-ylidene-N-nitroamine
428-650-4153719-23-4Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
 M = 10 
613-268-00-4(4aS-cis-)-6-benzyl-
octahydropyrrolo[3.4-b]pyridine
425-930-8151213-39-7Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H314
H332
H302
H373 **
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H314
H332
H302
H373 **
H411
   
613-269-00-X2-thiazolidinylidenecyanamide427-720-126364-65-8Acute Tox. 4*
STOT RE 2 *
Aquatic Chronic 3
H302
H373 **
H412
GHS08
GHS07
Wng
H302
H373 **
H412
   
613-270-00-55-amino-N-(2,6-dichloro-3-
methylphenyl)-1H-1,2,4-
triazole-3-sulfonamide
428-150-6113171-13-4Aquatic Chronic 3H412H412   
613-271-00-0tritosulfuron (ISO)
(containing ≤ 0,02 % AMTT);
1-[4-methoxy-6-(trifluoro-
methyl)-1,3,5-triazin-2-yl]-
3-[2-(trifluoromethyl)ben-
zenesulfonyl]urea (containing ≤ 0,02 % AMTT)
142469-14-5Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
 M = 10 
613-272-00-6pyraclostrobin (ISO);
methyl N-{2-[1-(4-chlorophenyl)-
1H-pyrazol-3-yloxymethyl]phe-
nyl}(N-methoxy)carbamate
Acute Tox. 3 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H331
H315
H400
H410
GHS06
GHS09
Dgr
H331
H315
H410
 M = 100 
613-273-00-1tetrahydro-3-methyl-5-((2-
phenylthio)thiazol-5-ylme-
thyl)-[4H]-1,3,5-oxadiazinan
-4-ylidene-N-nitroamine
427-600-9192439-46-6Aquatic Chronic 2H411GHS09H411   
613-274-00-72,6-dichloro-1-fluoropyri-
diniumtetrafluoroborate
427-400-1140623-89-8Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H302
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H302
H317
H410
   
613-275-00-23-(2-chloroethyl)-6,7,8,9-tetra-
hydro-2-methyl-4H-pyrido[1,2-a]
pyrimidin-4-one monohydrochloride
424-530-093076-03-0Acute Tox. 3 *
STOT SE 2
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H301
H371 **
H373 **
H318
H317
H411
GHS06
GHS05
GHS08
GHS09
Dgr
H301
H371 **
H373 **
H318
H317
H411
   
613-276-00-81-(2-chlorophenyl)-1,2-
dihydro-5H-tetrazol-5-one
426-110-298377-35-6Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
613-277-00-3(4-(6-diethylamino-2-methyl-
pyridin-3-yl)imino-4,5-dihydro-
3-methyl-1-(4-methylphenyl)-
1H-pyrazol-5-one
427-070-9Aquatic Chronic 4H413H413   
613-278-00-9(3-aminophenyl)pyridin-3-
ylmethanone
428-230-079568-06-2STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H400
H410
GHS08
GHS09
Wng
H373 **
H410
   
613-279-00-42-ethyl-2,3-dihydro-2-methyl-
1H-perimidine
424-380-643057-68-7Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 **
H410
   
613-280-00-Xtetrahydro-1,3-dimethyl-1H-
pyrimidin-2-one;
dimethyl propyleneurea
230-625-67226-23-5Repr. 2
Acute Tox. 4 *
Eye Dam. 1
H361f ***
H302
H318
GHS05
GHS08
GHS07
Dgr
H361f ***
H302
H318
   
613-281-00-5quinoline202-051-691-22-5Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H350
H341
H312
H302
H319
H315
H411
GHS08
GHS07
GHS09
Dgr
H350
H341
H312
H302
H319
H315
H411
   
613-282-00-0triticonazole (ISO);
(RS)-(E)-5-(4-chlorobenzyli-
dene)-2,2-dimethyl-1-(1H-1,2,4-
triazol-1-methyl)cyclopentanol
131983-72-7Aquatic Chronic 2H411GHS09H411   
613-283-00-6ketoconazole;
1-[4-[4-[[(2SR,4RS)-2-(2,4-
dichlorophenyl)-2-(imidazol-1-
ylmethyl)-1,3-dioxolan-4-yl]
methoxy]phenyl]piperazin-1-yl]
ethanone
265-667-465277-42-1Repr. 1B
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360F***
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H360F***
H301
H373 **
H410
   
613-284-00-1metconazole (ISO);
(1RS,5RS;1RS,5SR)-5-(4-
chlorobenzyl)-2,2-dimethyl-
1-(1H-1,2,4-triazol-1-
ylmethyl)cyclopentanol
125116-23-6Repr. 2
Acute Tox. 4 *
Aquatic Chronic 2
H361d ***
H302
H411
GHS08
GHS07
GHS09
Wng
H361d ***
H302
H411
   
613-285-00-71-hydroxybenzotriazole, anhydrous; [1]
1-hydroxybenzotriazole, monohydrated [2]
219-989-7 [1]
219-989-7 [2]
2592-95-2 [1]
123333-53-9 [2]
Expl. 1.3H203GHS01
Dgr
H203   
613-286-00-2potassium 1-methyl-3-
morpholinocarbonyl-4-[3-
(1-methyl-3-morpholino-
carbonyl-5-oxo-2-
pyrazolin-4-ylidene)-1-
propenyl]pyrazole-5-olate;
[containing < 0,5 % N,N-
dimethylformamide
(EC No 200-679-5)]
418-260-2183196-57-8Skin Sens. 1H317GHS07
Wng
H317   
613-286-01-Xpotassium 1-methyl-3-
morpholinocarbonyl-4-[3-
(1-methyl-3-morpholino-
carbonyl-5-oxo-2-
pyrazolin-4-ylidene)-1-
propenyl]pyrazole-5-olate;
[containing ≥ 0,5 % N,N-dimethylformamide
(EC No 200-679-5)]
418-260-2183196-57-8Repr. 1B
Skin Sens. 1
H360D ***
H317
GHS08
GHS07
Dgr
H360D ***
H317
   
613-287-00-81-(3-iodo-4-aminobenzyl)-
1H-1,2,4-triazole
419-540-7160194-26-3Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
   
613-288-00-31,3-bis(dimethylcarbamoyl)-
imidazolium chloride
420-930-4135756-61-5Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
   
613-289-00-93-(4-chloro-2-fluoro-5-
methylphenyl)-1-methyl-5-
(trifluoromethyl)-1H-pyrazole
432-020-4142623-48-1Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
613-290-00-44-hydroxy-7-(2-aminoethyl)-1,3-
benzothiazol-2(3H)-one hydrochlo-
ride
432-470-1189012-93-9Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H318
H317
H410
   
613-291-00-X2,4-dihydro-4-(4-(4-(4-
hydroxyphenyl)-1-
piperazinyl)phenyl)-2-(1-
methylpropyl)-3H-1,2,4-
triazol-3-one
434-820-9106461-41-0STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H400
H410
GHS08
GHS09
Wng
H373 **
H410
   
613-292-00-5N,N´,N´´-tris(2-methyl-2,3-
epoxypropyl)-perhydro-2,4,6-
oxo-1,3,5-triazine
435-010-826157-73-3Muta. 2
Aquatic Chronic 3
H341
H412
GHS08
Wng
H341
H412
   
613-293-00-02-(4-tert-butylphenyl)-6-cyano-5-
[bis(ethoxycarbonylmethyl)
carbamoyloxy]-1H-pyrrolo[1,2-b]
[1,2,4] triazole-7-carboxylic acid
2,6-di-tert-butyl-4-
methylcyclohexylester
448-050-6444065-11-6Aquatic Chronic 4H413H413   
613-294-00-62-hexyldecanoic acid
[4-(6-tert-butyl-7-chloro-1H-
pyrazolo[1,5-b][1,2,4]triazol-
2-yl)phenylcarbamoyl]me-
thylester
448-260-8379268-96-9Aquatic Chronic 4H413H413   
613-295-00-111-amino-3-chloro-6,11-dihy-
dro-5,5-dioxo-6-methyl-diben-
zo[c,f][1,2]thiazepine hydrochloride
448-720-8363138-44-7Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
   
613-296-00-7pentapotassium 2-(4-(5-[1-(2,5-
disulfonatophenyl)-4,5-dihydro-
3-methylcarbamoyl-5-oxopyra-
zol-4-ylidene]-3-methyl-1,3-
pentadienyl)-3-methylcarba-
moyl-5-oxidopyrazol-
1-yl)benzene-1,4-disulfonate
418-270-7Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
613-297-00-25-(2-bromophenyl)-2-tert-
butyl-2H-tetrazole
420-820-6Flam. Liq. 3
Acute Tox. 4 *
Aquatic Chronic 2
H226
H302
H411
GHS02
GHS07
GHS09
Wng
H226
H302
H411
   
613-298-00-8bis-(6-hydroxy-4-methyl-5-
(3-methylimidazolium-1-yl)-3-
(4-phenylazo)-1H-pyridin-2-
one)ethylene dilactate
421-560-6STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2
H373 **
H318
H411
GHS05
GHS08
GHS09
Dgr
H373 **
H318
H411
   
613-299-00-3main component 1 (isomer 1):
2-{6-fluoro-4-[3-(2,5-disulfo-
phenylazo)-4-hydroxy-2-
sulfonapht-7-ylamino]-
1,3,5-triazin-2-ylamino}-3-{6-
fluoro-4-[3-(1,5-disulfonaphth-
2-ylazo)-4-hydroxy-2-sul-
fonaphth-7-ylamino]-
1,3,5-triazin-2-ylamino}-
propane sodium salt;
main component 1 (isomer 2):
2-{6-fluoro-4-[3-(2,5-disulfo-
phenylazo)-4-hydroxy-2-
sulfonaphth-7-ylamino]-1,3,5-
triazin-2-ylamino}-3-{6-fluoro-4-
[3-(2,5-disulfo-phenylazo)-4-
hydroxy-2-sulfonaphth-7-
ylamino]-1,3,5-triazin-2-
ylamino}-propane sodium salt;
main component 2: 2,3-bis-
{6-fluoro-4-[3-(2,5-disulfo-
phenylazo)-4-hydroxy-2-
sulfonaphth-7-ylamino]-1,3,5-
triazin-2-ylamino}-propane sodium salt;
main component 3: 2,3-bis-{6-
fluoro-4-[3-(1,5-disulfonaphth-2-
ylazo)-4-hydroxy-2-sulfonaph-
th-7-ylamino]-1,3,5-triazin-2-
ylamino}-propane sodium salt
422-610-1Eye Dam. 1H318GHS05
Dgr
H318   
613-300-00-71-imidazol-1-yl-octadecan-2-ol434-120-3Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
613-301-00-2dimethyl-1-{[2-methoxy-5-(2-
methyl-butoxycarbonyl)phe-
nylcarbamoyl]-[2-octadecyl-
1,1-dioxo-1,2,4-benzothia-
diazin-3-yl]methyl}
imidazole-4,5-dicarboxylate
443-910-7Aquatic Chronic 4H413H413   
613-302-00-8disodium 2-(5-carba-
moyl-1-ethyl-2-hydroxy-4-
methyl-6-oxo-1,6-
dihydro-pyridine-3-ylazo)-4-
(4-fluoro-6-(4-(2-sulfonyloxy-
ethylsulfonyl)-phenylamino)-
1,3,5-triazine-2-ylamino)ben-
zene sulfonate
432-980-4243858-60-8Eye Dam. 1H318GHS05
Dgr
H318   
613-303-00-32-(1-methyl-2-(4-phenoxy-
phenoxy)ethoxy)pyridine
429-800-195737-68-1Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
613-304-00-95,6-dihydroxy-2,3-dihydro-1H-
indolium bromide
421-170-6138937-28-7Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
   
613-305-00-42-(2-hydroxy-4-octyloxy-
phenyl)-2H-benzotriazole
448-630-93147-77-1Aquatic Chronic 4H413H413   
613-306-00-X(2,5-dioxopyrrolidin-1-yl)-9H-
fluoren-9-ylmethyl carbonate
433-520-582911-69-1Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
   
613-307-00-5clothianidin (ISO);
3-[(2-chloro-1,3-thiazol-5-
yl)methyl]-2-methyl-1-
nitroguanidine
210880-92-5Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
 M = 10 
613-308-00-02-amino-5-methylthiazole423-800-57305-71-7Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 **
H410
   
613-309-00-61-methyl-3-phenyl-1-piperazine431-180-25271-27-2Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H312
H302
H315
H318
H412
GHS05
GHS07
Dgr
H312
H302
H315
H318
H412
   
613-310-00-1(-)(3S,4R)-4-(4-fluorophenyl)-3-
(3,4-methylenedioxy-
phenoxymethyl)-N-
benzylpiperidine hydrochloride
432-360-3105813-13-6Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
   
613-311-00-7methyl-5-nitrophenyl-guanidine435-500-1152460-07-6Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H302
H319
H317
H412
GHS07
Wng
H302
H319
H317
H412
   
613-312-00-22-(4-methyl-2-phenyl-1-
piperazinyl)benzenemethanol monohydrochloride
420-200-5Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412
   
613-313-00-82-(4-(4-(3-pyridinyl)-1H-imidazol-
1-yl)butyl)-1H-isoindole-1,3
(2H)-dione
442-780-9173838-67-0Aquatic Chronic 3H412H412   
613-314-00-34-decyloxazolidin-2-one;
4-decyl-1,3-oxazolidin-2-one
443-770-77693-82-5Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
613-315-00-9tetrapotassium 4-[5-[3-carboxylato-
4,5-dihydro-5-oxo-1-(4-
sulfonatophenyl)pyrazol-4-
ylidene]-3-(piperidinocarbo-
nyl)penta-1,3-dienylidene]-5-
hydroxy-1-(4-sulfonato-
phenyl)pyrazole-3-
carboxylate
430-390-1Acute Tox. 4 *
Aquatic Chronic 3
H332
H412
GHS07
Wng
H332
H412
   
613-316-00-4trimethylopropane
tri(3-aziridinylpropanoate);
(TAZ)
257-765-052234-82-9Muta. 2
Eye Dam. 1
Skin Sens. 1
H341
H318
H317
GHS05
GHS08
GHS07
Dgr
H341
H318
H317
   
613-317-00-Xpenconazole (ISO);
1-[2-(2,4-dichlorophenyl)pen-
tyl]-1H-1,2,4- triazole
266-275-666246-88-6Repr. 2
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
H361d
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H361d
H302
H410
 M = 1
M = 1
 
bis 30.11.2018:
613-318-00-5
fenpyrazamine (ISO);
S-allyl 5-amino-2-isopropyl-
4-(2-methylphenyl)-3-oxo-2,3-
dihydro-1H-pyrazole-1-
carbothioate
473798-59-3Aquatic Chronic 2H411GHS09H411   
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
613-318-00-5
Fenpyrazamine (ISO);
S-Allyl-5-amino-2,3-di-
hydro-2-isopropyl-3-oxo-
4-(o-tolyl)pyrazol-1-carbothioat;
S-Allyl-5-amino-2-isopropyl-
4-(2-methylphenyl)-3-oxo-2,3-
dihydropyrazol-1-
carbothioat
473798-59-3Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 10
M = 1
 
613-319-00-0Imidazol206-019-2288-32-4Repr. 1B
Acute Tox. 4
Skin Corr. 1C
H360D
H302
H314
GHS08
GHS07
GHS05
Dgr
H360D
H302
H314
   
613-320-00-6Lenacil (ISO); 3-Cyclohexyl-
6,7-dihydro-1H-cyclopenta[d]
pyrimidin-2,4(3H,5H)-dion
218-499-02164-08-1Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
 M = 10
M = 10
 
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
613-321-00-1
(RS)-4-[1-(2,3-Dimethyl-
phenyl)ethyl]-1H-imidazol;
Medetomidin
86347-14-0Acute Tox. 2
Acute Tox. 2
STOT SE 3
STOT SE 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H336
H370
(Augen)
H372
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H300
H336
H370
(Augen)
H372
H410
 M = 1
M = 100
 
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
613-322-00-7
Triadimenol (ISO);
(1RS,2RS;1RS,2SR)-1-(4-
Chlorphenoxy)-3,3-dimethyl-1-
(1H-1,2,4-triazol-1-yl)butan-2-ol;
α-tert-Butyl-β-(4-chlor-
phenoxy)-1H-1,2,4-triazol-1-
ethanol
259-537-655219-65-3Repr. 1B
Lact.
Acute Tox. 4
Aquatic Chronic 2
H360
H362
H302
H411
GHS08
GHS07
GHS09
Dgr
H360
H362
H302
H411
   
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
613-323-00-2
Terbuthylazin (ISO);
N-tert-Butyl-6-chlor-N'-
ethyl-1,3,5-triazin-2,4-
diamin
227-637-95915-41-3Acute Tox. 4
STOT RE 2
quatic Acute 1
Aquatic Chronic 1
H302
H373
H400
H410
GHS07
GHS08
GHS09
Wng
H302
H373
H410
 M = 10
M = 10
 
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
613-324-00-8
Chinolin-8-ol
8-Hydroxychinolin
205-711-1148-24-3Repr. 1B
Acute Tox. 3
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H360D
H301
H318
H317
H400
H410
GHS08
GHS06
GHS05
GHS09
Dgr
H360D
H301
H318
H317
H410
 M = 1
M = 1
 
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
613-325-00-3
Thiacloprid (ISO);
(Z)-3-(6-Chlor-3-pyridyl-
methyl)-1,3-thiazolidin-2-
ylidencyanamid;
{(2Z)-3-[(6-Chlorpyridin-
3-yl)methyl]-1,3-thiazoli-
din-2-yliden}cyanamid
111988-49-9Carc. 2
Repr. 1B
Acute Tox. 4
Acute Tox. 3
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H351
H360FD
H332
H301
H336
H400
H410
GHS08
GHS06
GHS09
Dgr
H351
H360FD
H332
H301
H336
H410
 M = 100
M = 100
 
bis 30.11.2018:
614-001-00-4
nicotine (ISO);
3-(N-methyl-2-pyrrolidinyl)py-
ridine
200-193-354-11-5Acute Tox. 1
Acute Tox. 3 (*)
Aquatic Chronic 2
H310
H301
H411
GHS06
GHS09
Dgr
H310
H301
H411
   
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
614-001-00-4
Nicotin (ISO);
3-[(2S)-1-Methylpyrroli-
din-2-yl]pyridine
200-193-354-11-5Acute Tox. 2
Acute Tox. 2
Acute Tox. 2
Aquatic Chronic 2
H330
H310
H300
H411
GHS06
GHS09
Dgr
H330
H310
H300
H411
 Einatmung:
ATE = 0,19
mg/L (Stäube oder Nebel)
Dermal:
ATE = 70 mg/kg
Oral:
ATE (*) = 5 mg/kg
(*) Umgerechnete Punktschätzung der akuten Toxizität gemäß der Tabelle 3.1.2 in Anhang I.